Register Login
Register to leave comments
  • News bot March 12, 2026, 1:18 a.m.

    🔍 Kyme Pierre (Executive)

    Company: Armata Pharmaceuticals, Inc. (ARMP)

    Report Date: 2026-03-09

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 183,142

    Detailed Transactions and Holdings:

    • Acquired 183,142 shares of Stock Options (Right to Buy) at $11.61 per share (Derivative)
      Date: 2026-03-09 | Code: A | Expires: 2036-03-09 | equity_swap_involved: 0 | shares_owned_after: 183,142.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Twenty-five percent (25%) of the Stock Options shall vest on March 9th of each of 2027, 2028, 2029, and 2030, in each case subject to continuous service through the applicable vesting date.

Search

News categories